Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Effects on fertility

Link to relevant study records
Reference
Endpoint:
screening for reproductive / developmental toxicity
Remarks:
based on test type (migrated information)
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
Study period:
2005-10-12 through 2007-07-30
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: GLP guideline study, but as read-across from supporting substance maximum reliability is 2. Read-across hypothesis: for details please see read-across report in IUCLID section 13.
Reason / purpose for cross-reference:
reference to same study
Qualifier:
according to guideline
Guideline:
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Deviations:
no
GLP compliance:
yes
Limit test:
no
Species:
rat
Strain:
other: Crl:CD (SD) IGS
Sex:
male/female
Route of administration:
oral: gavage
Vehicle:
water
Details on mating procedure:
- M/F ratio per cage: 1:1
- Length of cohabitation: 14 days
- Proof of pregnancy: sperm in vaginal smear; referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged (how): singly
Analytical verification of doses or concentrations:
yes
Duration of treatment / exposure:
Males 47-48 days; females 42-46 days
Frequency of treatment:
daily
Details on study schedule:
- Age at mating of the mated animals in the study: 13 weeks
Remarks:
Doses / Concentrations:
0, 37.5, 75, 100/150 mg/kg bw/day
Basis:
analytical conc.
No. of animals per sex per dose:
12
Control animals:
yes, concurrent vehicle
Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day (actual dose received)
Sex:
male
Basis for effect level:
other: see 'Remark'
Dose descriptor:
NOAEL
Effect level:
100 mg/kg bw/day (actual dose received)
Sex:
female
Basis for effect level:
other: see 'Remark'
Dose descriptor:
NOAEL
Generation:
F1
Effect level:
100 mg/kg bw/day (actual dose received)
Sex:
male/female
Basis for effect level:
other: no adverse effects on clinical signs; mortality; body weight live birth index; litter size; pup weight; sex ratio; survival index;
Reproductive effects observed:
not specified

Read-across hypothesis: for details please see read-across report in IUCLID section 13.

 

.There was no statistically significant change in any of the dose groups compared to the control group in any of the parameters examined in the parental animals or in the offspring. Detail infromation is contained in the attached document.

Conclusions:
There were no signs of toxicity to reproduction seen in parental animals or offspring in a valid OECD TG 422 oral gavage screening study using rats up to and including 100 mg octylamine hydrochloride/kg bw/day. The NOAEL for reproduction toxicity was therefore 100 mg/kg bw/day.
Executive summary:

Octylamine-HCl was examined for its potential for repeated toxicity, developmental and neurotoxicity in a combined OECD TG 422 study under GLP conditions. The dose levels used (0, 37.5, 75, an 100/150 mg/kg bw/day; oral gavage; 12 rats/sex/dose) were selected based on the results of two range finding studies, one in the range 100-1000 mg/kg bw/day, and one in the range 3-100 mg/kg bw/day. The high dose group was initially dosed at 150 mg/kg bw/day, but this was lowered 100 mg/kg bw/day by test day 14 because two mortalities were seen in this group. Therefore, this dose level is called “100/150 mg/kg bw/day”. It should however be mentioned that subsequent examinations revealed that these mortalities resulted from maldosing and were not related to the test substance.

 

The parameters examined in parental animals (gestation length, reproductive function indices [mating index, fertility index, gestation index, implantation efficiency], and corpora lutea counts] and in the offspring (viability at birth and on post partum day 4, sex ratio, weight at birth and on post partum day 4, clinical signs) were comparable across all groups including the control group. The NOAEL for reproduction toxicity was therefore 100 mg/kg bw/day under the conditions of this study.

Overall, there were no signs of toxicity to reproduction seen in parental rats or offspring in a valid OECD TG 422 oral gavage screening study receiving

octylamine hydrochloride up to and including 100 mg/kg bw/day (DuPont, 2007).
Effect on fertility: via oral route
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
100 mg/kg bw/day
Study duration:
subacute
Species:
rat
Quality of whole database:
reliable guideline study with RA substance octylamine-HCl
Effect on fertility: via inhalation route
Endpoint conclusion:
no study available
Effect on fertility: via dermal route
Endpoint conclusion:
no study available
Additional information

Octylamine-HCl was examined for its potential for repeated toxicity, developmental and neurotoxicity in a combined OECD TG 422 study under GLP conditions. The dose levels used (0, 37.5, 75, an 100/150 mg/kg bw/day; oral gavage; 12 rats/sex/dose) were selected based on the results of two range finding studies, one in the range 100-1000 mg/kg bw/day, and one in the range 3-100 mg/kg bw/day. The high dose group was initially dosed at 150 mg/kg bw/day, but this was lowered 100 mg/kg bw/day by test day 14 because two mortalities were seen in this group. Therefore, this dose level is called “100/150 mg/kg bw/day”. It should however be mentioned that subsequent examinations revealed that these mortalities resulted from maldosing and were not related to the test substance.

 

The parameters examined in parental animals (gestation length, reproductive function indices [mating index, fertility index, gestation index, implantation efficiency], and corpora lutea counts] and in the offspring (viability at birth and on post partum day 4, sex ratio, weight at birth and on post partum day 4, clinical signs) were comparable across all groups including the control group. The NOAEL for reproduction toxicity was therefore 100 mg/kg bw/day under the conditions of this study.

Overall, there were no signs of toxicity to reproduction seen in parental rats or offspring in a valid OECD TG 422 oral gavage screening study receiving

octylamine hydrochloride up to and including 100 mg/kg bw/day (DuPont, 2007).


Short description of key information:
No toxicity to reproduction was seen in parental rats or offspring in a valid OECD TG 422 oral gavage GLP screening study receiving
octylamine hydrochloride up to and including 100 mg/kg bw/day (DuPont, 2007).

Justification for selection of Effect on fertility via oral route:
only study available

Effects on developmental toxicity

Description of key information
No toxicity to reproduction was seen in parental rats or offspring in a valid OECD TG 422 oral gavage GLP screening study receiving
octylamine hydrochloride up to and including 100 mg/kg bw/day (DuPont, 2007).
Effect on developmental toxicity: via oral route
Endpoint conclusion:
no adverse effect observed
Dose descriptor:
NOAEL
100 mg/kg bw/day
Study duration:
subacute
Species:
rat
Quality of whole database:
reliable guideline study with RA substance octylamine-HCl
Effect on developmental toxicity: via inhalation route
Endpoint conclusion:
no study available
Effect on developmental toxicity: via dermal route
Endpoint conclusion:
no study available
Additional information

Octylamine-HCl was examined for its potential for repeated toxicity, developmental and neurotoxicity in a combined OECD TG 422 study under GLP conditions. The dose levels used (0, 37.5, 75, an 100/150 mg/kg bw/day; oral gavage; 12 rats/sex/dose) were selected based on the results of two range finding studies, one in the range 100-1000 mg/kg bw/day, and one in the range 3-100 mg/kg bw/day. The high dose group was initially dosed at 150 mg/kg bw/day, but this was lowered 100 mg/kg bw/day by test day 14 because two mortalities were seen in this group. Therefore, this dose level is called “100/150 mg/kg bw/day”. It should however be mentioned that subsequent examinations revealed that these mortalities resulted from maldosing and were not related to the test substance.

 

The parameters examined in parental animals (gestation length, reproductive function indices [mating index, fertility index, gestation index, implantation efficiency], and corpora lutea counts] and in the offspring (viability at birth and on post partum day 4, sex ratio, weight at birth and on post partum day 4, clinical signs) were comparable across all groups including the control group. The NOAEL for reproduction toxicity was therefore 100 mg/kg bw/day under the conditions of this study.

Overall, there were no signs of toxicity to reproduction seen in parental rats or offspring in a valid OECD TG 422 oral gavage screening study receiving

octylamine hydrochloride up to and including 100 mg/kg bw/day (DuPont, 2007).


Justification for selection of Effect on developmental toxicity: via oral route:
only study available

Justification for classification or non-classification

A reproductive and developmental NOAEL of 100 mg/kg bw/day (highest dose tested), determined in a combined repeated dose toxicity study with a reproduction/developmental toxicity screening test (OECD test guideline 422), indicates that no classification is required under Regulation (EC) No 1272/2008. There is no evidence of n-octylamine hydrochloride inducing adverse effects on parental fertility or development of offspring.

Additional information